CIK 0002093101 · <br>Emerging growth company
Atrium Therapeutics, Inc.
Sign in to watch- Ticker
- RNA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 394639499
- Phone
- 6198760700
- Business address
- 10578 SCIENCE CENTER DRIVE, SUITE 125, SAN DIEGO, CA
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-02-27 | Boyce Sarah Director | Grant or award · Stock Option (Right to Buy) | +20,000 | 20,000 | ||
| 2026-02-27 | BOESS CARSTEN Director | Grant or award · Stock Option (Right to Buy) | +20,000 | 20,000 | ||
| 2026-02-27 | WILSON TROY EDWARD Director | Grant or award · Stock Option (Right to Buy) | +20,000 | 20,000 | ||
| 2026-02-27 | Flanagan W. Michael Director | Grant or award · Stock Option (Right to Buy) | +20,000 | 20,000 | ||
| 2026-02-27 | Skerjanec Simona Director | Grant or award · Stock Option (Right to Buy) | +20,000 | 20,000 |
Page 2 of 2 · 25 trades